BIOAVAILABILITY AND DIURETIC EFFECT OF FUROSEMIDE FOLLOWING ADMINISTRATION OF TABLETS AND RETARDED CAPSULES TO HUMAN-SUBJECTS
Citation
N. Yagi et al., BIOAVAILABILITY AND DIURETIC EFFECT OF FUROSEMIDE FOLLOWING ADMINISTRATION OF TABLETS AND RETARDED CAPSULES TO HUMAN-SUBJECTS, Biological & pharmaceutical bulletin, 19(4), 1996, pp. 616-622
Categorie Soggetti
Pharmacology & Pharmacy
SICI code
0918-6158(1996)19:4<616:BADEOF>2.0.ZU;2-G
Abstract
Two kinds of dosage forms (tablets and retarded capsules) of furosemid
e (F) mere compared in vitro dissolution profile and in vivo absorptio
n studies. The dissolution of F from retarded capsules was extremely r
estricted in the first fluid of the JP XII disintegration test (within
0.8%), while the dissolution of F from tablets and retarded capsules
in the second fluid of JP XII disintegration test were both complete.
Metabolite specific assay of F showed F, conjugation of F with glucuro
nic acid (FG) and acyl migration isomers of FG (FG-iso) in urine or pl
asma. The mean cumulative urinary excretion of F following administrat
ion of the tablets during 24 h was twice that of retarded capsules. Th
e mean area under the plasma concentration-time curve (AUG) of F follo
wing administration of tablets was 1.5 times that of retarded capsules
, The mean cumulative urine volume during 24 h, however, was not signi
ficantly different between the two dosage forms. Clockwise hysteresis
relationships between the diuretic response and the urinary excretion
rate of F was observed after administration of retarded capsules. A st
raight relation between logarithm of the diuresis and logarithm of the
urinary excretion of F mas observed after maximum excretion rate of F
following administration of both dosage forms.